BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33495917)

  • 61. Identifying factors that impact survival among women with inflammatory breast cancer.
    Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
    Ann Oncol; 2012 Apr; 23(4):870-5. PubMed ID: 21765048
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
    Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
    Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epidemiology of male breast cancer.
    Konduri S; Singh M; Bobustuc G; Rovin R; Kassam A
    Breast; 2020 Dec; 54():8-14. PubMed ID: 32866903
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics?
    Curtis E; Quale C; Haggstrom D; Smith-Bindman R
    Cancer; 2008 Jan; 112(1):171-80. PubMed ID: 18040998
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Are Cure Rates for Breast Cancer Improved by Local and Regional Anesthesia?
    Tsigonis AM; Al-Hamadani M; Linebarger JH; Vang CA; Krause FJ; Johnson JM; Marchese E; Marcou KA; Hudak JM; Landercasper J
    Reg Anesth Pain Med; 2016; 41(3):339-47. PubMed ID: 26928797
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Breast cancer in octogenarian. Are we doing our best? A population-registry based study.
    Martinez-Ramos D; Simon-Monterde L; Queralt-Martin R; Suelves-Piqueres C; Menor-Duran P; Escrig-Sos J
    Breast; 2018 Apr; 38():81-85. PubMed ID: 29274475
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
    Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
    Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Caution Ahead: Research Challenges of a Randomized Controlled Trial Implemented to Improve Breast Cancer Treatment at Safety-Net Hospitals.
    Bickell NA; Shah A; Castaldi M; Lewis T; Sickles A; Arora S; Clarke K; Kemeny M; Srinivasan A; Fei K; Franco R; Parides M; Pappas P; McAlearney AS
    J Oncol Pract; 2018 Mar; 14(3):e158-e167. PubMed ID: 29298115
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment and survival of Asian women diagnosed with breast cancer in New Zealand.
    Lao C; Lawrenson R; Edwards M; Campbell I
    Breast Cancer Res Treat; 2019 Sep; 177(2):497-505. PubMed ID: 31168758
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of Access to Hospitals Most Ready to Achieve National Accreditation for Rectal Cancer Treatment.
    Antunez AG; Kanters AE; Regenbogen SE
    JAMA Surg; 2019 Jun; 154(6):516-523. PubMed ID: 30785616
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base.
    Mateo AM; Pezzi TA; Sundermeyer M; Kelley CA; Klimberg VS; Pezzi CM
    Ann Surg Oncol; 2017 Apr; 24(4):1050-1056. PubMed ID: 27807728
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hospital Characteristics and Breast Cancer Survival in the California Breast Cancer Survivorship Consortium.
    Shariff-Marco S; Ellis L; Yang J; Koo J; John EM; Keegan THM; Cheng I; Monroe KR; Vigen C; Kwan ML; Lu Y; Bernstein L; Wu AH; Gomez SL; Kurian AW
    JCO Oncol Pract; 2020 Jun; 16(6):e517-e528. PubMed ID: 32521220
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
    Li X; Zhang X; Liu J; Shen Y
    BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Overcoming sociodemographic factors in the care of patients with testicular cancer at a safety net hospital.
    Chertack N; Ghandour RA; Singla N; Freifeld Y; Hutchinson RC; Courtney K; Bowman IA; Arafat W; Meng X; Moore JA; Aydin AM; Sagalowsky AI; Margulis V; Lotan Y; Woldu SL; Bagrodia A
    Cancer; 2020 Oct; 126(19):4362-4370. PubMed ID: 32776520
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of Acute Cholecystitis at Safety-Net Hospitals: Analysis of the National Inpatient Sample.
    Singh S; Armenia SJ; Merchant A; Livingston DH; Glass NE
    Am Surg; 2020 Jan; 86(1):28-34. PubMed ID: 32077413
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South Korea.
    Kim HK; Lee SH; Kim YJ; Park SE; Lee HS; Lim SW; Cho JH; Kim JY; Ahn JS; Im YH; Yu JH; Park YH
    BMC Cancer; 2019 Jan; 19(1):84. PubMed ID: 30654765
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy.
    Tang R; Deng JP; Zhang L; Zhang WW; Sun JY; Chi F; Zhang J; Wu SG; He ZY
    BMC Cancer; 2022 Mar; 22(1):234. PubMed ID: 35241010
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Advanced Stage at Presentation Remains a Major Factor Contributing to Breast Cancer Survival Disparity between Public and Private Hospitals in a Middle-Income Country.
    Kong YC; Bhoo-Pathy N; Subramaniam S; Bhoo-Pathy N; Taib NA; Jamaris S; Kaur K; See MH; Ho GF; Yip CH
    Int J Environ Res Public Health; 2017 Apr; 14(4):. PubMed ID: 28420149
    [No Abstract]   [Full Text] [Related]  

  • 79. Treatment patterns and outcomes in older women with early breast cancer: a population-based cohort study in China.
    Liu X; Zheng D; Wu Y; Luo C; Fan Y; Zhong X; Zheng H
    BMC Cancer; 2021 Mar; 21(1):226. PubMed ID: 33673816
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The impact of hospital safety-net status on inpatient outcomes for brain tumor craniotomy: a 10-year nationwide analysis.
    Tang OY; Rivera Perla KM; Lim RK; Weil RJ; Toms SA
    Neurooncol Adv; 2021; 3(1):vdaa167. PubMed ID: 33506205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.